GHRP-6 Acetate 99%

Product Name GHRP-6 Acetate
Sequence
Cas No. 87616-84-0
Molecular Formula C46H56N12O6
Molecular Weight 873.01
Purity (HPLC) 98.0%min.
Appearance? White powder
Single Impurity (HPLC)? 1.0%max
Amino Acid Composition? ±10% of theoretical
Peptide Content (N%) ?≥80.0%
Water Content(Karl Fischer)? ≤6.0%
Acetate Content (HPIC) ≤12.0%
MS(ESI) Consistent
Mass Balance? 95.0~105.0%
Description:
GHRP-6 releasing hexapeptide) is one of several synthetic met-enkephalin analogs that include unnatural D-amino acids, were developed for their GH releasing activity and are called GH secretagogues. They lack opioid activity but are potent stimulators of GH release. These secretagogues are distinct from GHRH in that they share no sequence relation and derive their function through action at a completely different receptor. This receptor was originally called the GH secretagogue receptor, but due to subsequent discoveries, the hormone ghrelin is now considered the receptor's natural endogenous ligand. Therefore, these GH secretagogues act as synthetic ghrelin mimetics.
Application:
GHRP-6 is an injectable peptide in the category of releasing peptides, or GHRP's. The most common use of these peptides is to increase GH production. Other peptides in this category include GHRP-2, hexarelin, and ipamorelin. With regard to increasing GH, all of these work similarly, and there is no need or advantage to combining them. Instead, the one most suited for the particular case is chosen.
The principal use of GHRP-6 is to provide increased GH levels, which also results in increased IGF-1 levels. This aids fat loss and in some instances aids muscle gain as well. Generally, GHRP use is chosen as an alternate to GH use, and only rarely is combined with GH.